SAFE PHARMA SAVING LIFE
Our Mission
Supporting the transformation of the healthcare in the Middle East & develop a sustainable cost effective healthcare through delivering innovation at an affordable cost on the community
Our Vision
- Maximize cost efficiency
- Localizing global brands
- Provide insights to redefine care
- Expand to new markets
- Create sustainable partnerships
- Shape future trends & Enhance clinical specialization
Driving Your Business Forward
Through Partnership
Our Products
Introducing Kitelock 4%: Elevating CVAD Management
Kitelock 4%, an innovative lock solution for Central Venous Access Devices (CVAD), is now exclusively available through Safe Pharma in the UAE. Crafted meticulously by SterileCare in Ontario, Canada, Kitelock 4% has earned renown for its groundbreaking healthcare solutions, delivering unparalleled efficacy and safety in CVAD management.
Key Advantages of Kitelock 4%:
- Robust Defense Against Infections: Kitelock 4% features a unique formulation designed to prevent microbial colonization within CVAD lumens. This proactive approach significantly reduces the risk of bloodstream infections.
- Extended Catheter Patency: Beyond securing catheter lumens, Kitelock 4% actively promotes catheter longevity. By minimizing occlusions and blockages, it ensures uninterrupted patient care.
- User-Friendly Design: Healthcare professionals appreciate Kitelock 4% for its easy application. Streamlined usability makes it a preferred choice for efficient CVAD maintenance.
At Safe Pharma, we remain committed to excellence in healthcare products and services. Our mission is to empower UAE healthcare providers with cutting-edge solutions like Kitelock 4%, enhancing patient safety and outcomes.
Partnership with Safe Pharma
DIRECT, UNLIMITED ACCESS
